A new study conducted by Weill Cornell Medical College and the University of California San Diego and published in the journal Addiction found “that statewide medical cannabis legalization implemented in 1993 – 2014 in the U.S. was associated with close to 30% reductions in Schedule III opioids received by Medicaid enrollees.”

Click here for more detail.

Call Now Button

Pin It on Pinterest

Share This